1. Home
  2. LIQT vs LEXX Comparison

LIQT vs LEXX Comparison

Compare LIQT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$1.40

Market Cap

13.7M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.70

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIQT
LEXX
Founded
2004
2004
Country
Denmark
Canada
Employees
N/A
7
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
16.2M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
LIQT
LEXX
Price
$1.40
$0.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.30
$1.50
AVG Volume (30 Days)
8.6K
132.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.32
N/A
Revenue Next Year
$71.69
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$0.46
52 Week High
$3.35
$1.90

Technical Indicators

Market Signals
Indicator
LIQT
LEXX
Relative Strength Index (RSI) 39.90 47.95
Support Level N/A $0.58
Resistance Level $2.00 $0.87
Average True Range (ATR) 0.21 0.08
MACD -0.02 0.00
Stochastic Oscillator 10.00 38.33

Price Performance

Historical Comparison
LIQT
LEXX

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: